Larvol Delta - Longterm-Efficacy-and-Safety-Extension-LTE-Study-of-Barzolvolimab-in-Participants-With-Chronic-Spontaneous-Urticaria

barzolvolimab (CDX-0159) - Celldex

http://clinicaltrials.gov/ct2/show/NCT07256392

Jun 4, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next